Pfizer | China Business Law Journal



Home Tags Posts tagged with "Pfizer"

Tag: Pfizer

Out-licensing is in

China's out-licensing boom: legal experts share tips for seamless pharma deals

Han Kun advises 3SBio in landmark Pfizer licensing deal

3SBio inks major licensing deal with Pfizer for cancer drug SSGJ-707

Natasha Tuli fortifies Chandhiok & Mahajan’s corporate team

Natasha Tuli has joined Chandhiok & Mahajan as counsel in the corporate practice, based in New Delhi

LATEST ON LAW.ASIA

[TEST] EXTEND CACHE DEV

Korea Law Firm Awards

[TEST] Extend Cache

Laws and regulations on private equity funds in Japan

By Yuki Sato, Chiho Saito and Taiki Hashimoto, So & Sato Law Offices

Navigating legality and validity of non-competes

By Zhu Tao and Guo Zhiyan, ETR Law Firm

MOST READ ON LAW.ASIA

Correspondents

Delhi High Court anti-arbitration injunction Singapore

India to be an outlier in dispute resolution

By Sneha Jaisingh and Rasika Alur, Bharucha & Partners
Strategic investor definition for REITs and InvITsvideo

Reforms widen REITs and InvITs investor base

By Parag Bhide, Bharucha & Partners
Reasonable Criteria For Tax Deductibility In Philippines

Reasonable criteria for tax deductibility in Philippines

By Jacqueline Ann A Tan, ACCRALAW
Foreign direct investment in India’s hospital sector

Hospitals in India a healthy investment opportunity

By Anand Jayachandran and Aditya Prasad, Cyril Amarchand Mangaldas

Follow us on LinkedIn

Follow now